N = 123499 | |
---|---|
Demographics | |
Age, years, median (IQR) | 75 (70–81) |
Women, n (%) | 67207 (54.4) |
Income quintile, n (%) | |
One (lowest) | 24803 (20.1) |
Two | 24607 (19.9) |
Three (middle) | 25016 (20.3) |
Four | 23112 (18.7) |
Five (highest) | 24837 (20.1) |
Rural Location, n (%) | 25707 (20.8) |
Comorbidities, n (%) | |
Coronary artery disease¶ | 49027 (39.7) |
Diabetes mellitus£ | 28759 (23.3) |
Heart failure | 20259 (16.4) |
Peripheral vascular disease | 2730 (2.2) |
Stroke/Transient ischemic attack | 4812 (3.9) |
Medication use in prior 6 months, n (%) | |
Angiotensin-converting enzyme inhibitors | 49635 (40.2) |
Angiotensin-receptor blockers | 28438 (23.0) |
Beta blockers | 47051 (38.1) |
Calcium channel blockers | 40600 (32.9) |
Loop diuretics | 22860 (18.5) |
NSAIDs(excluding aspirin) | 26478 (21.4) |
Warfarin | 14967 (12.1) |
Potassium sparing diuretics | 9948 (8.1) |
Statins | 65168 (52.8) |
Thiazide diuretics | 27448 (22.2) |
Baseline Laboratory Measurements* | |
Serum creatinine μmol/L, median (IQR) | 84 (70–102) |
eGFR category ŦmL/min per 1.73m2, n (%) | |
≥60mL | 78584 (63.6) |
45-59 | 25904 (21.0) |
30-44 | 13749 (11.1) |
15-29 | 4624 (3.7) |
<15 | 638 (0.5) |
Serum sodium mmol/L, median, (IQR) | 140 (138–142) |
Serum potassium mmol/L, median (IQR) | 4.2 (3.9-4.6) |
Proteinuria (dipstick value) g/L | |
Category, n (%) | |
Negative | 23792 (19.3) |
0.3 | 1509 (1.2) |
1.0 | 962 (0.8) |
≥3.0 | 220 (0.2) |